Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TAF11L4 refers to a predicted or putative gene encoding a protein similar to TAF11, a canonical subunit of the transcription factor IID (TFIID) complex involved in the initiation of transcription by RNA polymerase II[2]. TAF11 is a small subunit of TFIID that interacts with TBP and forms a heterodimer with TAF13[3][5]. TAF11L4 is hypothesized to share some features of TAF11 but is annotated as "like 4", suggesting it is one of several paralogs or pseudogenes rather than a distinct protein with demonstrated function. It is predicted to enable protein heterodimerization and transcription initiation factor activity, to be part of the TFIID complex, and to be nuclear localized[2]. There is no published evidence of TAF11L4 as a characterized molecular target, receptor, transporter, or enzyme, nor is it considered a therapeutic target. No drugs, therapeutic mechanisms, or disease associations have been reported for TAF11L4[2]. - TAF11 is a functionally characterized subunit of TFIID, and its interaction with TAF13 and TBP is implicated in transcriptional regulation[1][3][5]. - TAF11L4 lacks functional validation and may represent a non-coding or pseudogene locus[2]. - The "like" nomenclature ("TAF11-like 4") commonly denotes sequence similarity but not necessarily conserved function or biological activity. - For structured database work, TAF11L4 should not be treated as an independently validated therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TATA-box binding protein associated factor 11 like 4 (TAF11L4).